Hong Kong Journal of Paediatrics is an esteemed publication dedicated to advancing knowledge in the field of Pediatrics, Perinatology, and Child Health. Published by MEDCOM LTD, this journal serves as a vital platform for researchers, clinicians, and academics to disseminate high-quality, peer-reviewed articles that address contemporary issues and developments in child health care and pediatrics. With an ISSN of 1013-9923, the journal has been actively publishing since 2005 and aims to contribute to the growing body of knowledge that aids healthcare professionals in improving patient outcomes. While currently categorized in the Q4 quartile of its field and ranked #251 out of 330 in Scopus's Pediatrics category, the journal's commitment to quality research remains steadfast, making it an important resource for those who wish to enhance their understanding and practice in this vital area of health. The journal is based in Hong Kong and aims to provide accessible content to a global audience, encouraging collaboration and innovation in pediatric healthcare.

Journal of Tropical Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of high-quality research within the field of tropical medicine. With an ISSN of 1687-9686 and E-ISSN 1687-9694, this journal has been providing an essential platform for researchers since 2009, facilitating a comprehensive understanding of diseases affecting tropical regions. Based in Egypt, the journal is categorized in the Q2 quartile for Medicine (miscellaneous) and Parasitology, alongside a Q3 rank in Microbiology as of 2023, highlighting its significant impact and relevance in these critical fields. The journal has earned commendable rankings within Scopus, being positioned 136th out of 636 in General Medicine, which reflects its role in advancing tropical health research. The Journal of Tropical Medicine is committed to promoting accessibility and knowledge sharing, making it an indispensable resource for professionals, researchers, and students dedicated to eradicating diseases and improving health outcomes in tropical settings.

Diseases is a premier Open Access journal dedicated to the dissemination of cutting-edge research in the field of medicine, particularly focusing on the multifaceted challenges posed by various diseases. Published by MDPI in Switzerland since 2013, this journal provides a platform for innovative studies and comprehensive reviews that address the latest developments in disease prevention, diagnosis, and treatment. With an E-ISSN of 2079-9721, it holds a respectable rank of #394 out of 636 in the General Medicine category according to Scopus, indicating a growing impact within the community, marked by its 38th percentile ranking. The journal, covering converged years from 2020 to 2024, aims to foster interdisciplinary collaboration and knowledge sharing among researchers, healthcare professionals, and students, ultimately contributing to the enhancement of global health outcomes. Accessible without charge, Diseases exemplifies a commitment to advancing research and practices aimed at improving human health on a global scale.

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

JMIR Public Health and Surveillance is a premier open access journal that has been at the forefront of public health research since its inception in 2015. Published by JMIR PUBLICATIONS, INC in Canada, this journal holds an impressive Q1 ranking in both Health Informatics and Public Health, Environmental and Occupational Health as of 2023. With a commendable Scopus Rank of #18 out of 665 in Public Health and #10 out of 138 in Health Informatics, JMIR Public Health and Surveillance stands out for its rigorous peer-reviewed articles that contribute significantly to the advancement of knowledge in these vital fields. The journal is committed to promoting research that advances the understanding and surveillance of health trends, disease outbreaks, and population health metrics, thus serving as an invaluable resource for researchers, professionals, and students alike. By facilitating open access to high-quality content, it ensures that results of critical public health research are readily available, ultimately helping to inform policy and public health initiatives across the globe.

Revista Chilena de Infectologia is an esteemed academic journal dedicated to the field of infectious diseases and public health. Published by the SOC CHILENA INFECTOLOGIA, this journal has been pivotal in disseminating crucial research findings since its inception in 2000. While operating under ISSN 0716-1018 and E-ISSN 0717-6341, it aims to contribute to the understanding of both local and global health issues, particularly within the context of Chile. Currently, it holds a Q4 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories as of 2023, reflecting its unique position among emerging voices in the field. The journal aspires to foster collaboration among researchers, professionals, and students by offering a platform for innovative studies and discussions that address pressing health challenges. Although it is not an Open Access journal, access options through institutional subscriptions are encouraged for a comprehensive review of its significant contributions to infectious disease research.